Cargando…

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

Detalles Bibliográficos
Autores principales:	Lu, Jun, Xu, Wei, Qian, Jie, Wang, Shuyuan, Zhang, Bo, Zhang, Lele, Qiao, Rong, Hu, Minjuan, Zhao, Yiming, Zhao, Xiaodong, Han, Baohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270796/ https://www.ncbi.nlm.nih.gov/pubmed/35804347 http://dx.doi.org/10.1186/s12920-022-01309-6

Ejemplares similares

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
por: Lu, Jun, et al.
Publicado: (2019)

Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
por: Lu, Jun, et al.
Publicado: (2019)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
por: Lu, Jun, et al.
Publicado: (2019)

Correction: Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
por: Koch, Christian, et al.
Publicado: (2023)

Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib
por: Sun, Xin, et al.
Publicado: (2020)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

Author Correction: Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
por: Huang, Bin, et al.
Publicado: (2023)

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
por: Liu, Qian, et al.
Publicado: (2022)

Correction: Identification of Genes Related to Growth and Lipid Deposition from Transcriptome Profiles of Pig Muscle Tissue
por: Wang, Zhixiu, et al.
Publicado: (2017)

Correction: Foam cells promote atherosclerosis progression by releasing CXCL12
Publicado: (2022)

Correction to: Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration
por: Li, Jing, et al.
Publicado: (2021)

Correction to: Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12
por: Lin, Chuangxin, et al.
Publicado: (2019)

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer
por: Zhao, Yiming, et al.
Publicado: (2021)

Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer
por: Xiong, Anning, et al.
Publicado: (2022)

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment
por: Dong, Changqing, et al.
Publicado: (2022)

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer
por: Yu, Lian, et al.
Publicado: (2022)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
por: Yang, Zhengyu, et al.
Publicado: (2021)

Correction: Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica
por: Liu, Zhu, et al.
Publicado: (2023)

Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
por: Chen, Ching, et al.
Publicado: (2023)

Correction: Unravelling the Transcriptome Profile of the Swine Respiratory Tract Mycoplasmas
Publicado: (2014)

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
por: Liu, Zhiyong, et al.
Publicado: (2021)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

Correction: Network regression analysis in transcriptome-wide association studies
por: Jin, Xiuyuan, et al.
Publicado: (2022)

Correction: Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease
Publicado: (2014)

Correction: CXCL10 Controls Inflammatory Pain via Opioid Peptide-Containing Macrophages in Electroacupuncture
Publicado: (2014)

Correction to: Targeted therapy with anlotinib for a H3K27M-mutant diffuse midline glioma patient with PDGFR‑α mutation: a case report
por: Wang, Qiang, et al.
Publicado: (2022)

Correction: Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion
por: Christensen, Stephen M., et al.
Publicado: (2017)

Correction: Transcriptomic profiling of the yeast Komagataella phaffii in response to environmental alkalinization
por: Albacar, Marcel, et al.
Publicado: (2023)

Correction: Transcriptome analysis of Phytolacca americana L. in response to cadmium stress
por: Chen, Yongkun, et al.
Publicado: (2018)

Correction to: CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
por: Blot, Mathieu, et al.
Publicado: (2021)

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Publicado: (2021)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Correction: Numerical Methods for the Analysis of Power Transformer Tank Deformation and Rupture Due to Internal Arcing Faults
por: Yan, Chenguang, et al.
Publicado: (2015)

Correction: CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12
Publicado: (2014)

Correction: Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection
por: Ahn, Sun-Hee, et al.
Publicado: (2018)

Correction: Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell
por: Ferdous, Farzana, et al.
Publicado: (2019)

Correction to: Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report
por: Liu, Liang, et al.
Publicado: (2021)

Correction: Identification of miRNAs involved in fruit ripening by deep sequencing of Olea europaea L. transcriptome
por: Carbone, Fabrizio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3v1cd233o5an4ffth9ci3e03eq